VANCOUVER, British Columbia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent...
VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) announces the filing of its annual financial...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
4 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
12 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
26 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
52 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
156 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
260 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約